Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00411Z
Serotype : AAV serotype Retrograde Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00411Z |
| Description | Premade self-complementary AAV particles in serotype Retrograde (scAAV Retrograde) express GFP reporter gene from the CAG promoter. |
| Gene | GFP |
| Serotype | AAV serotype Retrograde |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
| Target Gene | GFP |
Self-complementary adeno-associated virus retrograde serotype (scAAV Retrograde) is a powerful viral vector system that combines the advantages of AAV technology with significantly improved neuronal transduction efficiency. Unlike traditional single-stranded AAV vectors, scAAV particles package a double-stranded DNA genome, bypassing the rate-limiting step of second-strand synthesis, thus enabling faster and stronger transgene expression. The retrograde serotype further enhances the system''s capabilities, allowing for efficient axonal uptake and retrograde transport to the cell bodies of projecting neurons—a characteristic particularly important for targeting specific neural circuits. This vector system retains all the key advantages of AAV, including long-term transgene expression, low immunogenicity, and low toxicity, while overcoming the limitations of traditional AAV in neuronal applications.
scAAV Retrograde has become an indispensable tool in neuroscience research and potential therapeutic applications. Its ability to retrogradely deliver genetic material makes it ideal for mapping neural circuits, manipulating specific projecting neurons, and studying neurodegenerative diseases, where affected neurons may be distributed across multiple brain regions. Researchers utilize this vector for optogenetics, chemogenetics, and functional imaging studies, all of which require precise targeting of neuron populations defined by their projections. The rapid onset of expression is particularly important for time-sensitive experiments. In gene therapy development, scAAV Retrograde holds promise for treating diseases such as Parkinson''s disease, amyotrophic lateral sclerosis (ALS), and spinal cord injury, where treatment relies on targeting specific neuronal populations. The combination of efficient retrograde transport and immediate double-stranded expression gives scAAV Retrograde a unique advantage over traditional AAV vectors in both basic research and translational applications in the nervous system.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The customer service from Creative Biogene was extremely helpful in optimizing the use of scAAV Retrograde-CAG-GFP for our specific application needs. Their support enhanced our research outcomes.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.